Antibodies are Y-shaped protein molecules (immunoglobulins) produced by B-lymphocytes to neutralize pathogens .
They bind antigens via specific paratopes in the Fab region, triggering immune responses like complement activation and phagocytosis .
Subclasses (e.g., IgG, IgA, IgM) differ in structure and effector functions .
Relevance: While foundational antibody biology is well-documented, no data links these principles to "SPCC622.11".
MAB218/MAB218R: Human IL-11 antibodies used in neutralization assays and Western blotting .
REGN-COV2: A COVID-19 antibody cocktail targeting SARS-CoV-2 spike protein .
Anti-Kv1.4 antibodies: Autoantibodies linked to Myasthenia Gravis .
Analysis: These antibodies are unrelated to "SPCC622.11" and do not provide cross-referential insights.
No sources mention "SPCC622.11" in contexts such as:
Research applications (e.g., immunohistochemistry, ELISA).
Target antigens or therapeutic uses.
Structural or functional data.
The identifier "SPCC622.11" does not align with standard antibody nomenclature (e.g., IgG, mAb, or catalog numbers like MAB218).
Primary Sources: Consult specialized databases (e.g., CiteAb, AntibodyRegistry) or manufacturer catalogs for "SPCC622.11".
Literature Search: Use PubMed or Google Scholar with terms like "SPCC622.11 antibody" and "SPCC622.11 monoclonal".
Cross-Validation: Verify if "SPCC622.11" is a typo or variant name for an established antibody.
KEGG: spo:SPCC622.11
SPCC622.11 is a hypothetical protein identified in Schizosaccharomyces pombe (fission yeast) . It belongs to the LIMR family of proteins (LIMR family protein C622.11) and represents one of the open reading frames (ORFs) being investigated in fission yeast model systems. Its significance lies in its potential role in fundamental cellular processes being studied using the fission yeast model, particularly in the context of the TSC (Tuberous Sclerosis Complex) pathway research . Although classified as a hypothetical protein, understanding SPCC622.11's function may provide insights into conserved cellular mechanisms across species.
While direct evidence linking SPCC622.11 to the TSC pathway is limited, it has been identified in studies dissecting the TSC pathway in fission yeast . The TSC pathway is evolutionarily conserved from humans to fission yeast and regulates cellular responses to nutrient availability . In fission yeast, this pathway involves homologs of human TSC1/2, Rheb (called Rhb1 in yeast), and mTOR (Tor2 in yeast) . SPCC622.11 may be one of the components whose function is affected by or influences this signaling cascade, although its precise role requires further investigation.
For initial characterization of SPCC622.11, researchers should consider a multi-faceted approach:
Bioinformatic analysis - Sequence homology searches, structural predictions, and domain analysis to identify potential functions
Gene deletion/knockout studies - Creating SPCC622.11 null mutants to observe phenotypic effects
Protein localization - Using fluorescent tags or antibody-based detection to determine subcellular localization
Protein-protein interaction studies - Yeast two-hybrid, co-immunoprecipitation, or proximity labeling to identify interacting partners
Expression analysis - RNA-seq or qPCR to determine expression patterns under different conditions
These approaches will help establish fundamental properties of SPCC622.11 and generate hypotheses for more targeted functional studies.
Based on standard antibody applications for yeast proteins, SPCC622.11 antibody would typically be useful for:
Western blotting - To detect and quantify SPCC622.11 protein levels under different experimental conditions
Immunoprecipitation (IP) - To isolate SPCC622.11 and identify its binding partners
Chromatin immunoprecipitation (ChIP) - If SPCC622.11 is found to interact with DNA or chromatin-associated complexes
Immunofluorescence microscopy - To determine the subcellular localization of SPCC622.11
When working with hypothetical proteins like SPCC622.11, it's crucial to include proper controls to validate antibody specificity, such as using samples from knockout strains where the target protein is absent.
Validating antibody specificity is particularly important when working with hypothetical proteins like SPCC622.11:
Genetic validation - Test the antibody in wild-type yeast versus a SPCC622.11 deletion strain; absence of signal in the deletion strain confirms specificity
Overexpression validation - Compare signal between normal expression and overexpression systems; signal strength should correlate with expression level
Tagged protein comparison - Compare detection patterns between the native antibody and an epitope-tagged version of SPCC622.11
Preabsorption test - Preincubate the antibody with purified SPCC622.11 protein before immunostaining; this should eliminate specific signals
Multiple antibody validation - If available, use multiple antibodies targeting different epitopes of SPCC622.11 and compare results
Documentation of these validation steps is essential for publication-quality research involving novel or hypothetical proteins.
Given the connection between TSC pathway and nutrient sensing in fission yeast, investigating SPCC622.11's potential role in this process could involve:
Phenotypic analysis under nutrient starvation - Examine how SPCC622.11 deletion affects cellular responses to nitrogen starvation, similar to studies with Tsc1/2 mutants
Amino acid permease localization - Assess whether SPCC622.11 affects the localization of amino acid permeases, which is known to be regulated by the TSC/Rhb1 pathway
Transcriptional response analysis - Investigate if SPCC622.11 influences the expression of starvation-responsive genes like sxa2+ and mei2+
Epistasis analysis - Position SPCC622.11 within the TSC pathway by creating double mutants with tsc1, tsc2, rhb1, or tor2 and analyzing their phenotypes
Phosphorylation studies - Determine if SPCC622.11 is phosphorylated in response to nutrient conditions, possibly by Tor2 or other kinases in the pathway
These approaches would help elucidate whether SPCC622.11 functions upstream, downstream, or parallel to the core TSC signaling components .
To connect SPCC622.11 research with broader TSC pathway studies, researchers should:
Compare phenotypes - Systematically compare phenotypes of SPCC622.11 mutants with those of established TSC pathway components
Test rapamycin sensitivity - Determine if SPCC622.11 mutants show altered sensitivity to rapamycin, which targets TOR kinase
Examine interactions with Rhb1 - Investigate if SPCC622.11 interacts with or influences the activity of Rhb1 GTPase, particularly its GTP/GDP-bound states
Assess conservation - Identify potential homologs in higher organisms, including humans, to evaluate the broader relevance of findings
Create dominant active or inactive forms - Similar to studies with Rhb1-DA4 and Rhb1-DA8 mutants, engineer SPCC622.11 variants to test functional hypotheses
This integrative approach would position SPCC622.11 research within the established framework of TSC pathway knowledge while potentially revealing novel aspects of its function.
For hypothetical proteins like SPCC622.11, computational approaches can provide valuable functional insights:
Advanced homology modeling - Utilize tools like AlphaFold or RoseTTAFold to predict protein structure
Domain architecture analysis - Identify conserved domains or motifs that might suggest molecular function
Co-expression network analysis - Examine genes co-expressed with SPCC622.11 across multiple conditions to infer functional relationships
Phylogenetic profiling - Analyze the presence/absence pattern of SPCC622.11 across species to identify potential functional partners
Molecular dynamics simulations - For predicted structures, simulate protein behavior to identify potential binding sites or conformational changes
These computational predictions should be used to generate testable hypotheses that can be validated experimentally .
Researchers typically encounter several challenges when working with antibodies against hypothetical proteins:
Limited validation data - Unlike well-studied proteins, there is minimal literature to benchmark antibody performance
Unknown expression levels - Hypothetical proteins may be expressed at very low levels, requiring sensitive detection methods
Undefined post-translational modifications - Unknown modifications could affect antibody recognition
Cross-reactivity concerns - Without thorough characterization, potential cross-reactivity with related proteins remains a concern
Reagent availability - Commercial antibodies for hypothetical proteins are often produced on-demand with extended lead times
To address these challenges, researchers should implement rigorous controls and validation protocols for any experiments involving SPCC622.11 antibody.
Based on experience with similar yeast proteins, consider these protocol modifications:
Cell lysis optimization - Fission yeast has a robust cell wall; use specialized lysis buffers containing zymolyase or mechanical disruption methods
Protein extraction enhancement - Include specific detergents (0.1-1% NP-40 or Triton X-100) to improve membrane protein solubilization
Signal amplification - Consider using signal enhancement systems like tyramide signal amplification for immunofluorescence
Epitope retrieval - For fixed samples, test various antigen retrieval methods to improve epitope accessibility
Blockers optimization - Test different blocking reagents (BSA, milk, normal serum) to reduce background while preserving specific signal
These technical adaptations should be systematically tested and documented to establish optimal detection protocols for SPCC622.11.
The TSC pathway is implicated in several human diseases, including tuberous sclerosis complex. Research on SPCC622.11 could contribute to this field by:
Identifying novel pathway components - SPCC622.11 may represent a previously uncharacterized element in the TSC pathway
Revealing regulatory mechanisms - Studies may uncover how SPCC622.11 influences nutrient sensing or stress responses relevant to TSC function
Providing drug targets - If SPCC622.11 modulates the TSC pathway, it could represent a novel target for therapeutic intervention
Clarifying evolutionary conservation - Determining if SPCC622.11 functions are conserved in higher organisms could reveal foundational aspects of TSC signaling
Explaining rapamycin limitations - Research on fission yeast suggests that not all TSC-related functions are mediated through mTOR/Tor2; SPCC622.11 might be involved in mTOR-independent functions
These contributions would expand our understanding of TSC pathway biology beyond current paradigms focused primarily on Tsc1/2, Rheb, and mTOR.
Multidisciplinary collaborations could significantly advance SPCC622.11 research:
Structural biology partnerships - Collaborate with crystallography or cryo-EM experts to determine SPCC622.11 structure
Systems biology integration - Work with computational biologists to place SPCC622.11 in broader signaling networks
Comparative model organism studies - Partner with researchers studying related pathways in other model organisms to identify conserved functions
Proteomics collaborations - Engage with mass spectrometry experts to identify SPCC622.11 interactors and post-translational modifications
Translational research connections - Collaborate with clinical researchers studying TSC-related disorders to explore potential relevance of findings
Such collaborative approaches would provide complementary expertise and technologies to accelerate functional characterization of this hypothetical protein.